Qipeng Liu
Overview
Explore the profile of Qipeng Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Zhu S, Zhao D, Li C, Li Q, Jiang W, Liu Q, et al.
Oncogene
. 2019 Aug;
39(1):17-29.
PMID: 31462713
B lymphoma Mo-MLV insertion region 1 (BMI1) has been reported to be an oncoprotein. BMI1 represses tumor suppressors to promote cell proliferation, epithelial-mesenchymal transition (EMT), and cancer progression. Although it...
22.
Cao M, Liu Q, Chen M, Chen L, Yang D, Hu H, et al.
ACS Omega
. 2019 Aug;
3(12):18623-18629.
PMID: 31458429
Fully alloyed metallic nanomaterials have attracted much attention because of the superior chemical and physical properties to their single components. However, it has been difficult to make fully alloyed anisotropic...
23.
Guo W, Lu X, Liu Q, Zhang T, Li P, Qiao W, et al.
Cancer Med
. 2019 Jun;
8(9):4135-4148.
PMID: 31197958
Aims: This study aimed to evaluate the prognostic effect of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for patients with breast cancer (BC). Methods: A literature search was performed by...
24.
Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
Liu Q, Wang G, Li Q, Jiang W, Kim J, Wang R, et al.
Int J Cancer
. 2019 Jan;
145(2):415-426.
PMID: 30628724
Polycomb group proteins are important epigenetic regulators for cell proliferation and differentiation, organ development, as well as initiation and progression of lethal diseases, including cancer. Upregulated Polycomb group proteins, including...
25.
Zhang C, Hua H, Liu J, Han X, Liu Q, Wei Z, et al.
Nanomicro Lett
. 2018 Nov;
9(4):49.
PMID: 30393744
Ag-AgX(X = Cl, Br)@TiO nanoparticle-aggregated spheres with different mass ratio of = TiO/Ag(X) from 35:1 to 5:1 were synthesized by a facile sol-gel technique with post-photoreduction. The photocatalytic activities of...
26.
Liu Q, Li Q, Zhu S, Yi Y, Cao Q
Asian J Androl
. 2018 Jun;
21(3):224-232.
PMID: 29862993
B lymphoma Moloney murine leukemia virus insertion region 1 (BMI1), a core member of polycomb repressive complex 1 (PRC1), has been intensely investigated in the field of cancer epigenetics for...
27.
Prognostic and clinicopathological value of CXCL12/SDF1 expression in breast cancer: A meta-analysis
Liu H, Li Z, Deng M, Liu Q, Zhang T, Guo W, et al.
Clin Chim Acta
. 2018 May;
484:72-80.
PMID: 29800557
Background: Several studies have demonstrated that stromal cell derived factor-1 (SDF1, also known as CXCL12) expression is a biomarker for breast cancer treatment; however, its significance of prognosis is inconsistent....
28.
Qiao W, Liu H, Liu R, Liu Q, Zhang T, Guo W, et al.
Clin Chim Acta
. 2018 May;
483:209-215.
PMID: 29738697
Background: There are conflicting reports about the role of histone deacetylase 1 (HDAC1) in breast cancer prognosis. Here, we conducted a meta-analysis to investigate the prognostic significance of HDAC1 in...
29.
Zhu S, Zhao D, Yan L, Jiang W, Kim J, Gu B, et al.
Nat Commun
. 2018 Feb;
9(1):500.
PMID: 29402932
BMI1, a polycomb group (PcG) protein, plays a critical role in epigenetic regulation of cell differentiation and proliferation, and cancer stem cell self-renewal. BMI1 is upregulated in multiple types of...
30.
Qiao W, Jia Z, Liu H, Liu Q, Zhang T, Guo W, et al.
PLoS One
. 2017 Oct;
12(10):e0186191.
PMID: 29016671
Background: Despite initial indications that the transcription factor Twist could be used as a breast cancer prognostic marker, there still exists some controversy about its reliability. Thus, the aim of...